WebThe Diaceutics report follows comments made by John Castellani, ... At ASCO's annual meeting, Pfizer presented interim progression-free survival data for patients with ALK-positive advanced non-small cell lung cancer treated with an investigational ALK inhibitor, called crizotinib. The ongoing, open-label, multi-center, Phase I trial of 116 ... WebOct 20, 2024 · Why Invest in Diaceutics? Contacts; Advisers; Corporate Governance; Company Profile; Shareholder Information; Documents sent to shareholders; AIM Rule 26; Share Price Information; Analyst Research; …
Notice of AGM and posting of Annual Report - Investis Digital
WebDec 31, 2024 · Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built … WebJan 26, 2024 · -- Diaceutics said Thursday it secured two multi-year enterprise engagements for subscription data services, valued at $7 million. The pharmaceutical technology provider will supply two... March 31, 2024 ... Diaceutics PLC Reports Revenue Results for the Year Ended 31 December 2024: CI. 2024: TRADING UPDATES: … five drivers of knowledge management
- Diaceutics
WebThe Diaceutics’ Inclusion and Diversity Strategy will also monitor and report on these metrics Group wide. Diaceutics’ annual mentoring programme and City and Guilds … WebMar 10, 2024 · Diaceutics grew its revenue by 16% last year. We respect that sort of growth, no doubt. While the share price performed well, gaining 13% over twelve months, you could argue the revenue growth... WebApr 28, 2024 · 2:09 PM: (DXRX) Notice of AGM and Posting of Annual ReportRead more on 'Investegate' five drivers of productivity